Avi Oler | SVP, Corporate Development & General Counsel |
Steve Fruchtman | President & CEO |
Mark Guerin | CFO |
Ric Woodman | CMO |
Joe Pantginis | HC Wainwright |
Ahu Demir | Noble Capital Markets |
Yale Jen | Laidlaw & Company |
Good afternoon and welcome to Onconova Therapeutics' Corporate Update and Full Year 2019 Financial Results Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] As a reminder, this call maybe recorded.
At this time, I would like to turn the call over to Avi Oler, Senior Vice President of Corporate Development and General Counsel.
Thank you, operator.